- Daily Industry Report
- Posts
- Daily Industry Report - October 09
Daily Industry Report - October 09

Your summary of the Voluntary and Healthcare Industry’s most relevant and breaking news; brought to you by the Health & Voluntary Benefits Association®
Jake Velie, CPT | Robert S. Shestack, CCSS, CVBS, CFF |
White House launches AI taskforce
By Jill Barth – President Donald Trump has named Director of National Intelligence Jay Clayton to lead a new federal artificial intelligence task force, called the "Super Intelligence Force," as the administration tightens its approach to AI development, safety and U.S. competitiveness. Who is on the 'Super Intelligence Force'? The group will include Federal Trade Commission Chair Andrew Ferguson, Pentagon Chief Technology Officer Emil Michael and Office of Personnel Management Director Scott Kupor. It will report to Trump and White House Chief of Staff Susie Wiles, according to announcements reported by PBS NewsHour and other outlets. Read Full Article... (Subscription required)
HVBA Article Summary
Task force leadership and purpose: The White House appointed Director of National Intelligence Jay Clayton to lead a new federal AI task force branded as the “Super Intelligence Force.” The initiative is framed as part of a broader push to balance AI development with safety and U.S. competitiveness. The administration says the group will focus on maintaining U.S. leadership while prioritizing the interests of the American public.
Membership, reporting lines, and planned input: The task force is described as including FTC Chair Andrew Ferguson, Pentagon Chief Technology Officer Emil Michael, and Office of Personnel Management Director Scott Kupor. It is expected to report to President Trump and White House Chief of Staff Susie Wiles, as reported by outlets including PBS NewsHour. The administration also plans to solicit perspectives from a wide range of stakeholders, including consumers, public-interest organizations, religious groups, critical-infrastructure providers, and AI companies.
Relationship to executive order and potential employer relevance: The article distinguishes the task force from a separate Sept. 29 executive order titled Inaugurating the Era of Super Intelligence. While the piece notes the executive order does not itself create employer regulations, it suggests the task force could influence policy direction and clarify the federal role. It also flags the effort as worth monitoring for organizations using AI in employment-related contexts, especially given OPM’s involvement.
HVBA Poll Question - Please share your insightsWhat is the primary reason an organization considers adding a new voluntary benefit? |
Our last poll results are in!
33.33%
Of the Daily Industry Report readers who participated in our last polling question, when asked: “How are your clients handling GLP-1 coverage heading into 2027 renewals?” reported that they are focusing on “Lifestyle program requirements first.”
23.82.% of DIR respondents shared they are “Still figuring it out,” and 22.22% reported they are providing “Full coverage with PA.” The remaining 20.63% reported they are “Carving out entirely” GLP-1 coverage. Thank you to National Integrative Health for powering this polling question.
Have a poll question you’d like to suggest? Let us know!
No, Dr. Oz, Medicare Advantage Isn't "Stable"
By Wendell Potter – The Centers for Medicare & Medicaid Services recently released its annual preview of the Medicare Advantage and Part D plans that will be on the market when open enrollment begins a week from today. The Trump administration, CMS said, has successfully stabilized the Medicare Advantage program. Average premiums are projected to fall 16.5% next year, while drug premiums in Medicare Advantage plans are expected to drop 38%. Read Full Article...
HVBA Article Summary
Plan exits and market withdrawals are a major source of disruption: The article cites a Modern Healthcare analysis finding that at least 3.8 million people will need to choose new coverage because their insurer exited a market or ended a plan. It also describes broad reductions in plan offerings by major insurers, including large cuts by Humana and UnitedHealthcare, and Molina leaving the individual MA market. The piece adds that more counties are expected to have no Medicare Advantage plans at all, and some regional insurers получили permission to cap enrollment for 2027.
Lower headline premiums may coincide with higher cost-sharing and less usable coverage: The article reports that seniors who remain in their plans may still face higher financial exposure when they use care, including higher maximum out-of-pocket limits and rising Part D deductibles within Medicare Advantage plans. It gives examples such as UnitedHealthcare increasing its out-of-pocket limit and drug deductible, and an analysis cited from Stephens on average out-of-pocket increases (with variation by insurer). It also argues that insurers are shifting plan design toward tighter networks and benefit structures that can increase patient costs or limit access.
Averages can mask uneven impacts across plan types and beneficiaries: The article argues that CMS’s projected average premium decreases are influenced by growth in special needs plans, which tend to have lower premiums and are expanding. It contrasts these averages with analyses suggesting the typical consumer-facing Medicare Advantage drug plan premiums may be flat or rising, alongside fewer plan options. The piece also notes that CMS’s figures do not address changes that beneficiaries may feel directly, such as formulary changes, higher copays, or reduced generosity of supplemental benefits.
PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs?
By Christine Johnston – Healthcare premiums are expected to jump another 9% in 2027. The cost of care is reaching a point where some are forgoing health insurance entirely. Health plans and employers are looking for a cost-relief valve wherever they can. Earlier this year, Congress moved to lower pharmaceutical costs, passing the Consolidated Appropriations Act of 2026 (CAA of 2026). Read Full Article...
HVBA Article Summary
PBM transparency rules may be limited by revenue model shifts: The article explains that PBMs are already adjusting how they capture revenue ahead of the CAA of 2026 reporting requirements and in response to FTC-related settlements. It describes PBMs as expecting to preserve revenue by relabeling or restructuring charges within their own ecosystem rather than reducing total costs. As a result, the author argues that the law’s intended transparency could be weakened before the requirements are fully felt by employers.
Switching PBMs can be structurally difficult for employers: The piece outlines contract provisions that can make it hard to exit PBM relationships, including long termination notice periods and financial penalties tied to rebates or performance bonuses. It also highlights reconciliation periods after termination during which PBMs may adjust previously reported rebate figures, creating ongoing uncertainty. Separately, it notes that access to claims and operational data can be delayed, incomplete, or expensive, which can disrupt plan administration and member care during transitions.
Employers can focus on specific levers to manage pharmacy spend despite opacity: The author recommends evaluating PBMs on clinical management fundamentals such as prior authorization, formularies, and broader utilization controls. It also calls out high-impact categories like specialty drugs, GLP-1s, and biosimilars as areas where plan design and program structure can materially affect spending and outcomes. Finally, the article suggests that employers may need additional expertise—such as independent pharmacy advisors or coalitions—to interpret disclosures and push for auditable, claim-level transparency.
Costs and confusion dominate this open enrollment season
By Paola Peralta – The stakes are high this open enrollment season as employers and employees alike struggle to navigate changes to their benefit plans. Eighty-four percent of employers reported premium increases, according to an annual employer benchmarking report from national insurance brokerage and financial services firm company Alera Group, up from 81% in 2025. Thirty-four percent of those employers reported a price spike of 11% to 20%, making the upcoming open enrollment season one of the steepest periods of health cost increases in recent years. Read Full Article... (Subscription required)
HVBA Article Summary
Rising Healthcare Costs Challenge Employer Benefits Affordability: Employers are facing increasing healthcare expenses driven by higher costs of care, specialty medications, gene therapies, and broader political and regulatory factors. Many organizations are absorbing a significant portion of these increases rather than passing the full financial burden to employees, making it more difficult to maintain affordable and competitive benefits packages. These financial pressures are also complicating renewal negotiations and prompting employers and benefits leaders to explore alternative strategies for managing healthcare costs.
Supplemental Benefits Help Address Employee Coverage Gaps: Employers are increasingly considering supplemental insurance products, including accident, critical illness, cancer, and long-term care coverage, to help employees manage out-of-pocket expenses associated with higher-deductible health plans. These products can provide financial assistance for qualifying medical events, hospitalizations, treatments, and other healthcare needs that may not be fully covered by traditional health insurance. However, the effectiveness of supplemental benefits depends on employees understanding their coverage, eligibility requirements, and how to access available resources when needed.
Year-Round Benefits Education and Communication Become Essential: As employers expand their benefits offerings, employees face greater complexity in understanding available programs, selecting appropriate coverage, and navigating healthcare services. Benefits leaders are emphasizing year-round education, multichannel communication, and potentially AI-powered tools to deliver personalized information that addresses the preferences of a multigenerational workforce. Improving benefits literacy and engagement can help employees make more informed decisions, maximize the value of employer-sponsored programs, and support organizational goals related to cost management, employee satisfaction, and talent retention.
1 big thing: Medical debt hits more than 1 in 4 in U.S.
By Caitlin Owens – More than a quarter of Americans say they or their families were saddled with medical debt in 2025, including many with health insurance, according to a new Urban Institute study. Why it matters: The findings are an indicator of just how unaffordable care has become — and how having insurance is no longer a buffer against expensive medical bills. The big picture: Medical debt plagues higher proportions of the uninsured. But just 7.9% of Americans went without coverage last year. Read Full Article...
HVBA Article Summary
Rising Healthcare Costs Increase Financial Pressure on Insured Americans: A growing number of Americans with employer-sponsored or individual health insurance are struggling to afford deductibles, copayments, and out-of-network expenses, contributing to concerns about healthcare affordability. Medical debt has also become an issue in the upcoming midterm elections, including the closely contested Kansas Senate race between Republican Roger Marshall and Democrat Adam Hamilton. The issue highlights how having health insurance does not necessarily protect individuals and families from significant medical expenses and financial hardship.
Medical Debt Affects Millions of Americans Across Demographic Groups: According to an Urban Institute survey of more than 10,000 adults, 26.6% of Americans reported that they or a family member had medical debt, including 17.6% of Medicare-eligible seniors. More than half of adults with medical debt owed at least $1,000, while 15.5% owed $5,000 or more, with hospitals accounting for the largest share of outstanding medical bills. Medical debt was particularly prevalent among adults ages 45–54, lower-income households, individuals with disabilities, and those reporting fair or poor health, with 42% of the latter group carrying medical debt.
Policy Changes and Employer Healthcare Costs Could Intensify Affordability Challenges: Federal Medicaid spending reductions and the expiration of enhanced Affordable Care Act premium tax credits are expected to increase the number of uninsured Americans while raising premium costs for some individuals purchasing coverage. Employers are also facing another year of substantial healthcare cost increases, potentially resulting in higher employee premiums, deductibles, and other out-of-pocket expenses. As financial pressures grow, public attention is increasingly focused on medical billing practices, including requests for itemized bills, eligibility for financial assistance, and options for managing outstanding healthcare debt.
Renewals to results: the new broker playbook
By Bruce D. Roffe – Healthcare benefits brokers have evolved from simple “plan shoppers” into strategic consultants who use data, technology and alternative funding models to address their clients’ issues. Rising healthcare costs, higher frequency and severity of claims, along with increased complexity of healthcare, mean they must respond to employer demands beyond just annual program renewals. Today’s plan sponsors are now viewing their healthcare dollars through a wider lens and commanding brokers to provide information regarding financial risks and quantifiable measures of success. Read Full Article... (Subscription required)
HVBA Article Summary
Employers Shift Toward Year-Round Healthcare Cost Management: Rising healthcare costs are prompting employers to move beyond annual benefits renewals toward continuous financial oversight, risk management, and long-term cost-containment strategies. Employers are increasingly seeking greater transparency into the factors driving premium increases and whether higher spending translates into improved care, outcomes, or value. As a result, healthcare brokers are taking on expanded advisory roles, helping organizations evaluate alternative funding arrangements, specialty pharmacy strategies, and opportunities to improve healthcare spending efficiency.
Traditional Cost Management Approaches Face Increased Scrutiny: Conventional cost management strategies, including negotiated network discounts, PPO repricing, and retrospective payment adjustments, may reduce certain expenses but do not necessarily ensure accurate billing or claims adjudication. Complex, high-dollar medical claims often involve multiple providers, billing entities, and separately coded services, increasing the potential for processing errors and unnecessary financial exposure. Employers and brokers are increasingly examining claim-level cost containment strategies that focus on identifying billing inaccuracies, validating charges, and addressing potential overpayments before claims are paid.
Proactive Claims Review and Broker Expertise Become Increasingly Important: Earlier evaluation of medical claims allows employers and brokers to assess coding accuracy, billing relationships, supporting documentation, and the clinical justification for charges before payments are finalized. While technology can improve administrative efficiency and identify billing patterns, expert human review remains important for evaluating complex claims and addressing clinical and financial considerations. As employer expectations evolve, brokers are being encouraged to integrate data analytics, proactive claims validation, and financial oversight into their advisory services to support greater accountability, more predictable healthcare spending, and long-term plan sustainability.
Perimenopause Anxiety: Sometimes It's a Progesterone Deficiency
By Lexi Yoo – When women suddenly start feeling anxious in their 40s, the conversation needs to shift from serotonin and estrogen to understanding what’s happening to their progesterone levels. One of the biggest mistakes I see in perimenopause is assuming every symptom is caused by low estrogen. Hot flashes? Estrogen. Night sweats? Estrogen. Vaginal dryness? Estrogen. Read Full Article...
HVBA Article Summary
Progesterone’s role in midlife anxiety: The article argues that perimenopausal anxiety is often discussed through an estrogen- or serotonin-focused lens, which may miss a key driver for some women. It explains that progesterone commonly declines earlier and more consistently as ovulation becomes less reliable during perimenopause. That drop may contribute to symptoms such as irritability, poor stress tolerance, and a persistent “wired but tired” feeling. The author frames this as a reason some women don’t improve when care focuses only on estrogen-related explanations or treatments.
Hormone volatility vs. simple deficiency: Rather than a smooth, gradual hormone decline, the piece describes perimenopause as a period marked by significant variability, especially in estrogen from cycle to cycle. In contrast, progesterone may trend downward earlier because ovulation is less consistent, reducing progesterone production. This dynamic is presented as a reason symptoms can appear years before periods stop. The article links these shifts with experiences like panic attacks, palpitations, and heightened stress reactivity in some women.
Why evaluation and treatment may need a systems approach: The author notes that “normal” lab reference ranges may not align with how a person feels, and that isolated hormone numbers may miss broader physiology. The article emphasizes that progesterone interacts with brain signaling via metabolites that influence GABA pathways, and that sleep, blood sugar regulation, stress physiology, inflammation, and hormone metabolism can all affect symptoms. It recommends individualized clinical discussions that may include bioidentical progesterone therapy for some patients when appropriate. It also highlights supportive strategies such as addressing sleep and chronic stress and ensuring adequate magnesium intake, including prioritizing magnesium-rich foods.

Cigna unveils new customer experience platform, Health Sense
By Paige Minemyer – Cigna is rolling out a new patient experience platform that aims to harness the power of data to drive greater personalization. Called Health Sense, the tool brings together information on an individual's health needs, medical coverage, pharmacy benefits, cost exposure and other previous interactions with the health plan. This allows for more complete context, as the insurer's clinical teams offer tailored experiences to members. Read Full Article...
HVBA Article Summary
Platform goal is to reduce fragmentation for members: Cigna positions Health Sense as a way to help members avoid repeatedly re-explaining their situation while searching for coverage and care information. The platform is intended to present a more complete view of a member’s benefits and prior interactions so guidance can be more tailored. Company leadership framed the effort as addressing the frustration people face when navigating insurance and care, particularly for complex conditions.
Designed to support coordination and cost clarity without replacing clinicians: Cigna says the tool can help its clinical teams and care managers collaborate more effectively with treating providers by surfacing relevant context and next steps. It also aims to make cost exposure and out-of-pocket details easier for members to find, such as where they stand with deductibles. The company emphasizes the product is not meant to diagnose or prescribe, keeping medical decision-making with the patient and their doctor.
Phased rollout and condition-focused expansion plans: Cigna expects to begin rolling out Health Sense in early 2027, starting with members who have cancer or cardiometabolic conditions. The company describes these areas as priorities for employers and plan sponsors and as useful starting points for testing and learning what interventions work. It also signals potential expansion into other areas like sleep, musculoskeletal issues and acute needs if the approach proves effective.






